Ascorbic acid solution 5%, 2ml No. 10

- Treatment of hypo- and avitaminosis C (if it is necessary to quickly replenish vitamin C and the impossibility of oral administration).

- Used for medicinal purposes in all clinical situations associated with the need for additional administration of ascorbic acid, including: parenteral nutrition, diseases of the gastrointestinal tract.

- In laboratory practice.

Applied as directed by a doctor.

Ascorbic acid is administered orally (after meals), intramuscularly or intravenously.

For prophylactic purposes, adults are prescribed 0.05 g-0.1 g per day; during pregnancy, in the postpartum period and in the case of a low content of vitamin C in the milk of lactating women, 0.3 g per day is prescribed for 10-15 days, after which, prophylactically, 0.1 g per day during the entire lactation period.

Children are prescribed prophylactically 0.025 g 2-3 times a day.

Therapeutic doses for adults are when taken orally - 05-0.1 g 3-5 times a day; for children - 0.05-0.1 g 2-3 times a day.

Therapeutic doses for adults with parenteral administration are 1-3 ml of a 5% solution (2-6 ml of a 2.5% solution) per day. Children are prescribed parenterally 1-2 ml of a 5% solution (2-4 ml of a 2.5% solution) per day. The course of treatment depends on the nature and course of the disease.

ascorbic acid 50 mg in 1 ml

- Hypersensitivity to the components of the drug,

- with long-term use in large doses (more than 500 mg) - diabetes mellitus,

- hyperoxaluria,

- nephrolithiasis,

- hemochromatosis,

- thalassemia,

- deficiency of glucose-6-phosphate hydrogenase.

With care:

Diabetes mellitus, glucose-6-phosphate hydrogenase deficiency, hemochromatosis, sideroblastic anemia, thalassemia, hyperoxaluria, kidney stones.

Indications:

- Treatment of hypo- and avitaminosis C (if it is necessary to quickly replenish vitamin C and the impossibility of oral administration).

- Used for medicinal purposes in all clinical situations associated with the need for additional administration of ascorbic acid, including: parenteral nutrition, diseases of the gastrointestinal tract.

- In laboratory practice.

Contraindications:

- Hypersensitivity to the components of the drug,

- with long-term use in large doses (more than 500 mg) - diabetes mellitus,

- hyperoxaluria,

- nephrolithiasis,

- hemochromatosis,

- thalassemia,

- deficiency of glucose-6-phosphate hydrogenase.

With care:

Diabetes mellitus, glucose-6-phosphate hydrogenase deficiency, hemochromatosis, sideroblastic anemia, thalassemia, hyperoxaluria, kidney stones.

Pregnancy and lactation:

The use of the drug during pregnancy and lactation is possible only as directed by a doctor if the intended benefit to the mother outweighs the potential risk to the fetus or baby.

Method of administration and dosage:

Intramuscularly, intravenously (slowly).

Adults from 100 to 500 mg (2 to 10 ml of 50 mg / ml solution) per day, in the treatment of scurvy - up to 1000 mg per day.

Children from 100 to 300 mg (2 - 6 ml of 50 mg / ml solution) per day, in the treatment of scurvy - up to 500 mg (10 ml of 50 mg / ml solution) per day.

Side effects:

From the side of the central nervous system: with rapid intravenous administration - headache, dizziness, fatigue; with prolonged use of large doses (more than 1 g) - headache, increased excitability of the central nervous system, insomnia.

From the urinary system: moderate pollakiuria (when using a dose of more than 600 mg / day), with prolonged use of large doses of hyperoxaluria, nephrolithiasis (from calcium oxalate), damage to the glomerular apparatus of the kidneys.

From the side of the cardiovascular system: with prolonged use of large doses - a decrease in capillary permeability (possible deterioration of tissue trophism, increased blood pressure, hypercoagulation, development of microangiopathies).

Allergic reactions: skin rash, skin flushing.

Laboratory indicators: thrombocytosis, hyperprothrombinemia, erythropenia, neutrophilic leukocytosis, hypokalemia, glucosuria.

Local reactions: soreness at the site of intramuscular injection.

Symptoms: nephrolithiasis, insomnia, irritability, hypoglycemia.

Treatment: symptomatic, forced diuresis.

Storage conditions:

In a dark place at a temperature of 5 to 25 ? C.

Keep out of the reach of children.

Expiration date:

1 year 6 months.

Do not use after the expiration date.

Pharmacy Dispensing Terms:

Prescription